New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

PPHvsPBPHETF Comparison

ETF 1
PPH

VanEck Pharmaceutical ETF

This fund is part of
Uncategorized Equities
+0.01%
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
-0.09%

VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. Both ETFs have the same top 1 sector exposures: Healthcare. PPH is more expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.13% for PBPH. PPH is up 12.3% year-to-date (YTD) with -$320M in YTD flows. PBPH performs better with 14.86% YTD performance, and +$954M in YTD flows. Run a side-by-side ETF comparison of PPH and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PPH vs PBPH performance and flow charts

Performance

0246810%Aug 4Aug 11Aug 18Aug 25Sep 1

Cumulative Flows

0 M20 M40 M60 M80 M100 MAug 4Aug 11Aug 18Aug 25Sep 1

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/04/2026
1M3MYTD1Y3Y5Y
Perf.
PPH
PBPH
+5.68%+7.33%
+9.41%+13.03%
+12.30%+14.86%
+31.03%n/a
+49.60%n/a
+65.29%n/a
Flows
PPH
PBPH
+$90M+$21M
+$77M+$140M
-$320M+$954M
+$197M-
+$364M-
+$441M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PPH
PBPH
+20.98%+19.80%
+18.43%n/a
+16.11%n/a
+15.58%n/a
Max drawdown
PPH
PBPH
-4.80%-4.94%
-10.78%n/a
-17.98%n/a
-20.19%n/a
Max drawdown duration
PPH
PBPH
21d20d
122dn/a
434dn/a
484dn/a
Trading data

Create an account to view trading data

Join for free
PPH
PBPH
Last sale
9/4/2026 at 1:30 PM
$114.21
$29.01
Previous close
09/03/2026
$115.77
$29.39
Consolidated volume
09/03/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PPH
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/4/2026 at 1:30 PM
Live
Closed
PPH
PBPH
Last price
$114.21
$29.01
1D performance
-1.35%
-1.29%
AuM$1.05 B$1.04 B
E/R0.36%0.13%
Characteristics
PPH
PBPH
Management strategyPassivePassive
ProviderVanEckTidal
BenchmarkMVIS US Listed Pharmaceutical 25 IndexBITA Global Pharma and Biotech Select Index
N° of holdings2552
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011November 24, 2025
ESGNoNo
Advertisement
Exposure

Countries

PPH
USA
60.93%
United Kingdom
11.44%
Switzerland
10.54%
Other
17.1%
PBPH
USA
65.24%
Switzerland
10.52%
United Kingdom
7.15%
Other
17.09%

Sectors

PPH
Healthcare
100%
Other
0%
PBPH
Healthcare
99.46%
Other
0.54%
Advertisement

Diversification

PPH

Total weight of top 15 holdings out of 15

90.28%
PBPH

Total weight of top 15 holdings out of 15

75.4%

Top 15 holdings

Data as of July 31, 2026
PPH
Eli Lilly & Co.
19.11%
Novartis AG
10.54%
Merck & Co., Inc.
9.76%
Novo Nordisk A/S
5.67%
Bristol Myers Squibb Co.
4.94%
McKesson Corp.
4.64%
AbbVie, Inc.
4.59%
Pfizer Inc.
4.58%
Johnson & Johnson
4.31%
GSK Plc
4.31%
Sanofi
3.95%
AstraZeneca PLC
3.84%
Cencora, Inc.
3.63%
Haleon Plc
3.29%
Teva Pharmaceutical Industries Ltd.
3.14%
PBPH
Eli Lilly & Co.
15.14%
Johnson & Johnson
9.55%
AbbVie, Inc.
7.06%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.70%
Amgen, Inc.
4.62%
Novartis AG
4.45%
AstraZeneca PLC
3.88%
Gilead Sciences, Inc.
3.77%
Novo Nordisk A/S
3.75%
Pfizer Inc.
3.28%
Bristol Myers Squibb Co.
3.06%
Vertex Pharmaceuticals, Inc.
2.82%
GSK Plc
2.24%
Sanofi
2.10%
Frequently asked questions about PPH and PBPH

How have the PPH and PBPH ETFs performed in 2026?

As of September 4, 2026, PPH is up 12.3% year-to-date (YTD), while PBPH has returned 14.86%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PPH or PBPH?

Year-to-date, the PPH ETF saw -$320M in flows, compared to +$954M for PBPH.

Which ETF is bigger: PPH or PBPH?

As of September 4, 2026, PPH holds $1.05 B in assets under management (AUM), while PBPH manages $1.04 B.

What sectors do the PPH and PBPH ETFs invest in?

PPH leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the PPH ETF and PBPH ETF?

PPH top holdings include Eli Lilly & Co., Novartis AG and Merck & Co., Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: PPH or PBPH?

PPH holds 25 securities with 90.28% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 75.4%.

Advertisement
Latest news about PPH & PBPH
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder